Filing Flows › Comparisons › RAPP vs ADCT
Rapport Therapeutics vs ADC Therapeutics SA: RAPP and ADCT compared
Rapport Therapeutics is the larger company: $20.0M of revenue in its latest quarter (Q1 2026) against $19.2M for ADC Therapeutics SA (Q2 2026). Rapport Therapeutics is more profitable, with an operating margin of -121.1% against -132.0%.
Where the money goes: RAPP and ADCT
Rapport Therapeutics (RAPP) · Q1 2026
Rapport Therapeutics, Q1 2026: revenue $20.0M, operating margin -121.1%, net loss $19.9M, operating cash flow −$13.1M. The chart follows the revenue to costs, profit and cash.
ADC Therapeutics SA (ADCT) · Q2 2026
ADC Therapeutics SA, Q2 2026: revenue $19.2M (+2% year over year), operating margin -132.0%, net loss $16.6M, operating cash flow −$11.8M. The chart follows the revenue to costs, profit and cash.
| Rapport Therapeutics (RAPP) | ADC Therapeutics SA (ADCT) | |
|---|---|---|
| Latest quarter | Q1 2026 | Q2 2026 |
| Revenue | $20.0M | $19.2M |
| Revenue growth, Y/Y | — | +2% |
| Operating margin | -121.1% | -132.0% |
| Net earnings | −$19.9M | −$16.6M |
| Net margin | -99.3% | -86.1% |
| Operating cash flow | −$13.1M | −$11.8M |
Where the revenue comes from
ADC Therapeutics SA
- Product revenues, net: $18.6M (97%)
- Royalties: $614K (3%)
Questions
Which is bigger, Rapport Therapeutics or ADC Therapeutics SA?
Rapport Therapeutics is the larger company: $20.0M of revenue in its latest quarter (Q1 2026) against $19.2M for ADC Therapeutics SA (Q2 2026).
Is Rapport Therapeutics or ADC Therapeutics SA growing faster?
Rapport Therapeutics is more profitable, with an operating margin of -121.1% against -132.0%.
More: Rapport Therapeutics earnings · how Rapport Therapeutics makes money · ADC Therapeutics SA earnings · how ADC Therapeutics SA makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed May 7, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.